Dr. Filippo Della Marina

Biotechnology, Cytometry, Research-Biotech, Clinical. Sales. Account Management.

Sales and counseling in the field of vascular and peripheral intervention solutions. Vascular Surgery devices. Endovascular procedures. Innovative products in thrombectomy, AVF, radiofrequency, etc... Relationship with clients from public and private sector. Analysis of market trends, needs, threats, and opportunities. Implementation of business and sales plans. Support the client in all technical and economic aspects. Develop and maintain KOL relations. Tender management.

Sales of diagnostic solutions in the microbiology/virology field Relationship with clients from public and private sector Analysis of market trends, needs, threats, and opportunities Implementation of business and sales plans Support the client in all technical and economic aspects Develop and maintain KOL relations Tender management

Founded in 1993, Alcimed is a consulting firm specialized in Innovation and New Businesses, with special focus on innovative sectors such as Life Sciences (Biotech, Healthcare, Food), Energy, Aeronautics, ICT, Chemicals, and others. Our mission is to help our clients to explore new uncharted territories such as: • New Technologies • Market Innovation • Growing Countries • Strategic Foresight Our clients include world leader industries, start-up, innovative SMEs and private equity players.

I work in an interdisciplinary environment, managing a small team and communicating complex scientific data to a scientific as well as a non-scientific public. -Managing and supervising complex research projects -Planning and following-up experimental procedures -Writing project reports -Team management and coaching -Managing daily activity in the laboratory -Training technical staff -Oral and written presentation of results to partners and during meetings (posters) -Leading workshops

My work concerns an extremely aggressive type of leukemia in which more than 80% of patients present genetic abnormalities that result in poor response to present therapies. During my PhD (obtained in November 2015) I have acquired experties in preclinical pharmacological analysis in both in vivo and in vitro systems. I develop my communication skills and acquired excellent capabilities in discussing complex research projects with a scientific as well as a non-scientific public.